Skip to main content
Caplight Logo









Shenzhen Sangel Venture Capital

Shenzhen Sangel Venture Capital

Shenzhen, Guangdongsangelvc.com

Overview

Sangel Capital is one of the earliest established healthcare venture capital firms in China. Dedicated to novel technologies and healthcare innovation, the firm focuses on investing in startups in biotech, biopharma, medical devices, and digital health . Sangel Capital provides venture capital and business finance to support high-tech enterprises in China and Western countries .

Year Founded

2009

Portfolio Companies

14

Investments

Shenzhen Sangel Venture Capital investments
CompanyDateStageLead
BriSTAR ImmunotechOct 2021Series BCo-investor
PersonGen BioTherapeuticsMay 2021Series ACo-investor
深圳英美达医疗技术有限公司Apr 2021Series CCo-investor
PredicineJul 2020Series BCo-investor
Guangzhou Magpie Pharmaceuticals Co., Ltd.Feb 2019Series BLead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShenzhen, Guangdong
Year Founded2009

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?